Search

everythinglearnresearchcommunity

for

Search:↓

Balding and low testosterone increase risk of urinary stones.

Metformin is less effective in men with early-onset hair loss.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Hirsutism in young girls can have various causes beyond PCOS, so diagnoses should be reconsidered if treatments don't work.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Premature hair loss doesn't increase the risk of metabolic syndrome.